Business | Convalescent
The pandemic is a chance to revamp India’s pharmaceutical industry
Companies could switch from primarily making generics to producing higher-margin licensed drugs
|DELHI
This article appeared in the Business section of the print edition under the headline “Convalescent”
Business May 9th 2020
- The pandemic will recast America’s health-care industrial complex
- The pandemic is a chance to revamp India’s pharmaceutical industry
- The French establishment closes ranks to help Lagardère
- Chinese carriers restart their engines
- Parks and resorts powered Disney’s growth. Then came covid-19
- Japanese offices struggle to adapt to social distancing
- Don’t stand so close to me
- The buoyant oil traders
From the May 9th 2020 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Business
Germans are world champions of calling in sick
It’s easy and it pays well
Knowing what your colleagues earn
The pros and cons of greater pay transparency
A $500bn investment plan says a lot about Trump’s AI priorities
It’s build, baby, build
Donald Trump’s America will not become a tech oligarchy
Reasons not to panic about the tech-industrial complex
OpenAI’s latest model will change the economics of software
The more reasoning it does, the more computer power it uses
Donald Trump once tried to ban TikTok. Now can he save it?
To keep the app alive in America, he must persuade China to sell up